Goldman Sachs Group »

Conduit Pharmaceuticals shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Conduit Pharmaceuticals (CDT) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Conduit Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Conduit Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Conduit Pharmaceuticals by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $252k 69k 3.67

More positions owned by Goldman Sachs Group

Spdr S&p 500 Etf Tr CMN (SPY)
Microsoft Corp CMN (MSFT)
Nvidia Corporation CMN (NVDA)
Apple CMN (AAPL)
Amazon CMN (AMZN)
Ishares Tr CMN (IWM)
Ishares Tr CMN (IVV)
Invesco Qqq Tr CMN (QQQ)
Meta Platforms CMN (META)
Alphabet CMN (GOOGL)
Vanguard Index Fds CMN (VOO)
Tesla CMN (TSLA)
Visa CMN (V)
Ishares Tr CMN (HYG)
Ishares Tr CMN (EFA)

View all positions for Goldman Sachs Group

Top funds holding Conduit Pharmaceuticals

Barclays
Vanguard Group
BlackRock
Geode Capital Management
Goldman Sachs Group
Marshall Wace
Qube Research & Technologies
Jpmorgan Chase & Co
Northern Trust
Y-Intercept
Morgan Stanley
Bank Of Montreal
Bank of America Corporation
Tower Research Capital
Wells Fargo & Company

View all funds holding Conduit Pharmaceuticals